Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2013
11/12/2013US8580279 Compounds
11/12/2013US8580273 TNF superfamily member light fusion proteins
11/12/2013US8580262 Group B Streptococcus antigens
11/12/2013US8580260 Method of using anti-IL-13 antibodies
11/12/2013US8580246 Surfactant-free stable pharmaceutical composition comprising granulocyte-colony stimulating factor
11/12/2013CA2714357C Mutations in neuronal gene sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
11/12/2013CA2664637C Dried reconstituted vesicle formation for pharmaceutical application
11/12/2013CA2611924C Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
11/12/2013CA2609811C Angiotensin i - converting enzyme (ace) inhibitors
11/12/2013CA2607113C Interleukin-1 receptor antagonists, compositions, and methods of treatment
11/12/2013CA2536643C Interferon-.beta. complex
11/12/2013CA2499458C Protein s protects the nervous system from injury
11/12/2013CA2493142C Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers
11/12/2013CA2477012C Anti-a.beta. antibodies and their use
11/12/2013CA2471924C Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases, and for modulation of cell survival and/or death
11/12/2013CA2407872C Receptor-based interaction trap
11/12/2013CA2342376C A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
11/12/2013CA2296071C Production and use of recombinant protein multimers with altered biological activity
11/12/2013CA2213451C Generation of human cytotoxic t-cells specific for carcinoma self-associated antigens and uses thereof
11/07/2013WO2013166320A1 Legume isoprene synthase for production of isoprene
11/07/2013WO2013166234A1 Modified prokaryotic ubiquitin-like protein and methods of use thereof
11/07/2013WO2013166075A1 Cobalamin acquisition protein and use thereof
11/07/2013WO2013166053A2 Homogenous and fully glycosylated human erythropoietin
11/07/2013WO2013165963A1 Treatment of thrombocytopenia using orally administered interferon
11/07/2013WO2013165732A1 Process for purifying recombinant plasmodium falciparum circumsporozoite protein
11/07/2013WO2013165613A1 Methods of treating and preventing staphylococcus aureus infections and associated conditions
11/07/2013WO2013165590A1 Methods for treating idiopathic pulmonary fibrosis
11/07/2013WO2013165554A1 Methods and compositions for modulating g-alpha-q signaling
11/07/2013WO2013164763A2 A biological complex specific for alzheimer's disease detection in vitro and use thereof
11/07/2013WO2013164703A1 Plants having enhanced yield-related traits and method for making same
11/07/2013WO2013164694A1 Targeted/immunomodulatory fusion proteins and methods for making same
11/07/2013WO2013164484A1 Glucagon-like-peptide-2 (glp-2) analogues
11/07/2013WO2013164483A1 Gip-glp-1 dual agonist compounds and methods
11/07/2013WO2013164444A1 Method and pharmaceutical composition for use in the treatment and diagnotic of anemia of inflammation
11/07/2013WO2013164435A2 CANINE THYMIC STROMAL LYMPHOPOIETIN PROTEIN FUSION PROTEIN WITH THE Fc REGION OF IgG
11/07/2013WO2013164405A1 Spider silk fusion protein structures without repetitive fragment for binding to an organic target
11/07/2013WO2013164404A1 Spider silk fusion protein structures incorporating immunoglobulin fragments as affinity ligands
11/07/2013WO2013163727A1 Protecting modified viruses from neutralizing antibodies using the reovirus sigma 1 protein
11/07/2013WO2013163724A1 Protecting modified viruses from neutralizing antibodies using the reovirus sigma 1 protein
11/07/2013WO2013163684A1 Fatty acid modification and tag assembly genes
11/07/2013WO2013163681A1 Fluorescent proteins and uses thereof
11/07/2013WO2013138363A3 Genetic reduction of male fertility in plants
11/07/2013WO2013110818A3 Immunogens for hiv vaccination
11/07/2013WO2013084071A3 Clostridium difficile toxin-based vaccine
11/07/2013WO2012140620A8 Compositions for preventing and/or treating an infection by an hiv-1 virus
11/07/2013WO2011156000A3 Use of il-4/il-13 antagonists to treat eosinophilic disorders
11/07/2013WO2003048322A9 Dna encoding orphan snorf4 receptor
11/07/2013WO2003033664A9 Bone anti-resorptive compounds
11/07/2013WO2003023002A9 Novel human proteins, polynucleotides encoding them and methods of using the same
11/07/2013WO2002101075A9 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
11/07/2013WO2002083860A9 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
11/07/2013WO2002079443A3 Transgenic mice containing 5-ht5b serotonin receptor gene disruptions
11/07/2013US20130296541 Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
11/07/2013US20130296534 Fusion protein having factor ix activity
11/07/2013US20130296528 Preparation and/or formulation of proteins cross-linked with polysaccharides
11/07/2013US20130296404 Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same
11/07/2013US20130296258 Muteins of human lipocalin 2 with affinity for glypican-3 (gpc-3)
11/07/2013US20130296257 Cobalamin acquisition protein and use thereof
11/07/2013US20130296255 Methods and Reagents for Treatment of Age-Related Macular Degeneration
11/07/2013US20130296249 Methods of blocking tissue destruction by autoreactive t cells
11/07/2013US20130296247 Analogs of Sodium Channel Peptide Toxin
11/07/2013US20130296244 Variant of antihemophilic factor viii having increased specific activity
11/07/2013US20130296242 Medication and therapy treating of choroidal neovascularization
11/07/2013US20130296241 Aquaretic and natriuretic polypeptides lacking vasodilatory activity
11/07/2013US20130296240 Pneumonia biomarkers
11/07/2013US20130296227 Antimicrobial cationic peptides and formulations thereof
11/07/2013US20130296225 Microcrystalline Y Receptor Agonists
11/07/2013US20130296221 Improved capping modules for designed ankyrin repeat proteins
11/07/2013US20130295687 Novel Method of Isolation of TLR4 from Cell Lysates of Mononuclear Cells
11/07/2013US20130295667 Serum-free mammalian cell culture medium, and uses thereof
11/07/2013US20130295666 Crystals of glucokinase regulatory protein (gkrp)
11/07/2013US20130295646 Method for extracting a protein from milk
11/07/2013US20130295610 Chimeric antigens for eliciting an immune response
11/07/2013US20130295609 Plant expression system
11/07/2013US20130295608 Yeast strain for the production of proteins with modified o-glycosylation
11/07/2013US20130295595 Modified prokaryotic ubiquitin-like protein and methods of use thereof
11/07/2013US20130295593 Truncated human vitamin d binding protein and mutation and fusion thereof and related materials and methods of use
11/07/2013US20130295132 Conjugation of Streptococcal Capsular Saccharides
11/07/2013US20130295128 Chimeric vaccines
11/07/2013US20130295125 Compositions and methods relating to mouse papilloma virus
11/07/2013US20130295121 Covalent Diabodies and Uses Thereof
11/07/2013US20130295101 Ricin Vaccine and Methods of Making Thereof
11/07/2013US20130295099 N-linkedglycan compounds
11/07/2013US20130295094 Use of a vegf antagonist to treat angiogenic eye disorders
11/07/2013US20130295093 Fusion constructs containing active sections of tnf ligands
11/07/2013US20130295077 Treatment of sanfilippo syndrome type b
11/07/2013US20130295063 High affinity hiv t cell receptors
11/07/2013US20130295021 Human anti-tau antibodies
11/07/2013US20130295010 Her2 binding peptides labelled with a 18f - containing organosilicon compound
11/06/2013EP2660335A2 Highly conserved genes and their use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify algal, archaeal, bacterial, fungal and parasitical microorgamisms from clinical specimens for diagnosis
11/06/2013EP2660320A1 Modified tamavidin
11/06/2013EP2660250A1 TCR transgenic mouse model for immune disease
11/06/2013EP2660249A1 Peptide derivative and use thereof
11/06/2013EP2660247A2 High penetration prodrug compositions of peptides and peptide-related compounds
11/06/2013EP2659893A2 T cell regulation
11/06/2013EP2659771A1 Transgenic plants having increased biomass
11/06/2013EP2658979A1 Compositions comprising natriuretic peptides and methods of use thereof
11/06/2013EP2658976A2 Nucleic acid molecules that target the rho1 small gtp-binding protein and confer resistance to coleopteran pests
11/06/2013EP2658975A2 Nucleic acid molecules that target the vacuolar atpase h subunit and confer resistance to coleopteran pests
11/06/2013EP2658867A1 Non-natural mic proteins
1 ... 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 ... 2916